Davita inc
DVA 投資分析
看多重點:
- 價值≥4
- 股利≥2
分析結論
價值面評分優異,但股利評分未超過2分,若公司開始配息,可能會有更優異的投資結果
DVA 近期報酬表現
1.18%
Davita inc
2.86%
同產業平均
0.86%
S&P500
與 DVA 同產業的標的表現
股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
---|---|---|---|---|---|---|---|
FMS | Fresenius medical care ag | 4 分 | 3 分 | 2 分 | 1 分 | 5 分 | |
SGRY | Surgery partners inc | 3 分 | 1 分 | 2 分 | 4 分 | 1 分 | |
THC | Tenet healthcare corporation | 5 分 | 5 分 | 3 分 | 2 分 | 1 分 | |
BKD | Brookdale senior living inc. | 2 分 | 5 分 | 3 分 | 3 分 | 1 分 | |
MD | Pediatrix medical group inc | 2 分 | 3 分 | 3 分 | 2 分 | 1 分 |
- FMS Fresenius medical care ag價值 4 分趨勢 3 分波段 2 分籌碼 1 分股利 5 分查看更多
DVA 公司資訊
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company's robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company's international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company's U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.